Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro

Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro

Abstract Effective vaccines are slowing the COVID-19 pandemic, but SARS-CoV-2 will likely remain an issue in the future making it important to have therapeutics to treat patients. There are few options for treating patients with COVID-19. We show probenecid potently blocks SARS-CoV-2 replication in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jackelyn Murray, Robert J. Hogan, David E. Martin, Kathy Blahunka, Fred D. Sancilio, Rajiv Balyan, Mark Lovern, Richard Still, Ralph A. Tripp
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/d191ef95cc404745a8ce8416434d12ad
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/d191ef95cc404745a8ce8416434d12ad

Ejemplares similares